Severe Infection Tied to Substance-Induced Psychosis Severe Infection Tied to Substance-Induced Psychosis
Severe infection is linked to an increased risk of substance-induced psychosis. However, hepatitis is the most strongly linked and the only infection tied to schizophrenia conversion.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - February 21, 2020 Category: Infectious Diseases Tags: Psychiatry News Source Type: news

Big investment needed to eliminate hepatitis C in Pakistan could deliver huge health benefits
A large investment of at least US$3.9 billion needed to meet the World Health Organisation ’ s (WHO) target for the elimination of Hepatitis C virus (HCV) in Pakistan could deliver huge benefits in terms of lives saved and reduced ill health, according to University of Bristol led research published in The Lancet Global Health today [19 February]. (Source: University of Bristol news)
Source: University of Bristol news - February 20, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences; Press Release Source Type: news

Africa: Advocates, Policy Makers to Develop Common Agenda for Improving Health Outcomes for People Who Use Drugs - INHSU Africa
[International Network on Hepatitis in Substance Users] Cape Town -INHSU Africa 2020 continued today with advocates and policy makers coming together toidentify common agendas in the quest to improve health outcomes for people who use drugsacross the African region. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 19, 2020 Category: African Health Source Type: news

HCV Eradication With DAAs Reduces Variceal Bleeding Risk HCV Eradication With DAAs Reduces Variceal Bleeding Risk
This study found that DAA-induced SVR in patients with hepatitis C is associated with a reduced risk of variceal bleeding, among both patients with and without established cirrhosis.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 19, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Big investment needed to eliminate Hep C in Pakistan could deliver huge health benefits
(University of Bristol) A large investment of at least US$3.9 billion needed to meet the World Health Organization's (WHO) target for the elimination of Hepatitis C virus (HCV) in Pakistan could deliver huge benefits in terms of lives saved and reduced ill health, according to University of Bristol led research published in The Lancet Global Health today [19 February]. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 19, 2020 Category: Infectious Diseases Source Type: news

Few Perinatally Exposed Infants Receive Recommended Hep C Testing Few Perinatally Exposed Infants Receive Recommended Hep C Testing
Fewer than a quarter of infants exposed perinatally to hepatitis C virus (HCV) undergo testing for the virus, according to a database study.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 18, 2020 Category: Pathology Tags: Gastroenterology News Source Type: news

Measles Complications Can Affect Every Organ: Study
TUESDAY, Feb. 18, 2020 -- Hepatitis, appendicitis and viral meningitis are among the serious complications that can occur when you get the measles, doctors warn in a new report. The study -- which outlines cases involving three adults who developed... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 18, 2020 Category: General Medicine Source Type: news

Gut Microbiota Dysbiosis in HBV-induced Chronic Liver Disease Gut Microbiota Dysbiosis in HBV-induced Chronic Liver Disease
Using a gene sequencing approach, this study examined the gut microbiota profile of patients with hepatitis B virus-induced chronic liver disease compared with healthy controls.Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 18, 2020 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news

Impact of Delaying DAA Treatment for Chronic Hepatitis C Impact of Delaying DAA Treatment for Chronic Hepatitis C
What is the impact of delaying treatment for different populations of people living with hepatitis C? The authors present a clinical decision tool for informing treatment timing decisions.Liver International (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - February 18, 2020 Category: Surgery Tags: Gastroenterology Journal Article Source Type: news

Africa: INHSU Africa 2020 Kicks Off With Advocates Gathering to Plan on Improving Health Outcomes For People Who Use Drugs
[International Network on Hepatitis in Substance Users] INHSU Africa, a historic meeting of researchers, policy makers, politicians and advocates to plan for the elimination of viral hepatitis for people who use drugs has commenced today with a planning session for advocates across the African region. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 17, 2020 Category: African Health Source Type: news

Complications of measles can include hepatitis, appendicitis, and viral meningitis, doctors warn
(BMJ) The complications of measles can be many and varied, and more serious than people might realise, doctors have warned in the journal BMJ Case Reports after treating a series of adults with the infection. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 17, 2020 Category: International Medicine & Public Health Source Type: news

Taiwan reports first death from coronavirus
Taxi driver with diabetes and hepatitis B is fifth fatality outside mainland ChinaA taxi driver has died from the coronavirus in Taiwan, marking the first such death on the island and the fifth fatality outside mainland China from an epidemic that has curbed travel and disrupted global supply chains.The health minister, Chen Shih-chung, said during a news conference on Sunday that the deceased was a 61-year-old man who had diabetes and hepatitis B. Taiwan has to date reported 20 confirmed cases.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - February 16, 2020 Category: Science Authors: Rebecca Ratcliffe and agencies Tags: Coronavirus outbreak Taiwan China Infectious diseases Medical research Science World news Asia Pacific Source Type: news

Tennessee infants exposed to hepatitis C at birth often not tested for virus
(Vanderbilt University Medical Center) Most Tennessee infants exposed to hepatitis C at birth are not later tested to see if they acquired the virus, according to a study by researchers at Monroe Carell Jr. Children's Hospital at Vanderbilt and the Vanderbilt Center for Child Health Policy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 14, 2020 Category: International Medicine & Public Health Source Type: news

Zimbabwe: Boost for Viral Hepatitis Fight
[The Herald] ADDIS ABABA -Zimbabwe and other African countries are roping in technical partners to bolster their fight against viral hepatitis. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 13, 2020 Category: African Health Source Type: news

HCV Eradication With DAA Improves Insulin Resistance HCV Eradication With DAA Improves Insulin Resistance
This study aimed to assess whether SVR after direct-acting antivirals could improve the degree of insulin resistance in HCV-infected patients, including those with cirrhosis.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 11, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

STDs on the rise: The evidence of claims data
(FAIR Health) Private Insurance Claim Lines for STDs Rose 76% from 2007 to 2018 Gonorrhea Claim Lines Increased 326 Percent among Males, FAIR Health Study Shows. Hepatitis B Was the Leading STD on the Rise in People over 60. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 11, 2020 Category: Infectious Diseases Source Type: news

Pharmacology of Current and Investigational HBV Therapies Pharmacology of Current and Investigational HBV Therapies
Currently, a functional cure for hepatitis B virus infection is rare. This review summarizes the efficacy, safety and pharmacology of the many compounds under investigation for the treatment of HBV.Alimentary Pharmacology & Therapeutics (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 10, 2020 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news

Mauritius: Free Medication for Hepatitis C Patients
[Government of Mauritius] Free medication will be provided by a UK-based biopharmaceutical company, Gilead Sciences, to patients suffering from hepatitis C in Mauritius under a medicine donation programme, announced yesterday, the Prime Minister, Minister of Defence, Home Affairs and External Communications, Minister for Rodrigues, Outer Islands and Territorial Integrity, Mr Pravind Kumar Jugnauth. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - February 7, 2020 Category: African Health Source Type: news

Hexavalent Vaccine Included in Vaccines for Children Program
FRIDAY, Feb. 7, 2020 -- The hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenza type b (Hib) conjugate (meningococcal protein conjugate), and hepatitis B... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 7, 2020 Category: Pharmaceuticals Source Type: news

Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b Conjugate, and Hepatitis B Vaccine, and Guidance for Use in Infants
A new combination vaccine to prevent diphtheria, tetanus, whooping cough, polio, Haemphilus influenzae type b disease, and hepatitis B has been licensed, but won't be available before 2021. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - February 6, 2020 Category: American Health Tags: Diphtheria Vaccination Hepatitis B Vaccination MMWR Morbidity & Mortality Weekly Report Pertussis Vaccination Tetanus Vaccination Vaccine-Preventable Diseases and Specific Vaccines Whooping cough Source Type: news

Dr. Chen Liu appointed the Brady Professor of Pathology
Liu is an expert in viral hepatitis, liver cancer immunotherapy, graft-versus-host disease, and cancer epigenetics. (Source: Yale Science and Health News)
Source: Yale Science and Health News - February 6, 2020 Category: Universities & Medical Training Source Type: news

Cells to Society: Year of the Nurse / Global Impact
This study establishes baseline sociodemographic and clinical characteristics of hospitalized patients in Nepal who were experiencing heart failure.     Read more   Maternal Health ...
Source: Johns Hopkins University and Health Systems Archive - February 6, 2020 Category: Nursing Source Type: news

ACIP Releases 2020 Child and Adolescent Vaccine Schedule ACIP Releases 2020 Child and Adolescent Vaccine Schedule
Changes include a recommendation for a hepatitis A catch-up vaccination for anyone who wasn't vaccinated as a child.News Alerts (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - February 4, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Alert Source Type: news

Baby Boomers Have High Incidence Of Hepatitis C Virus: What Does This Mean, Boomer?
In the 1960 ’s-1980’s, the years before utilization of universal precaution and infection control, transmission of the Hepatitis C virus, via contaminated medical equipment, or contact with contaminated blood products, led to easy transmission of this virus from either person to person or via cont... (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 4, 2020 Category: Pharmaceuticals Authors: Nina Shapiro, Contributor Source Type: news

Liver Safety Assessment in Trials of New Agents for HBV Liver Safety Assessment in Trials of New Agents for HBV
What are the challenges in interpreting liver safety data in trials of investigational agents for chronic HBV? Review the laboratory, clinical and histological criteria which must be considered.Journal of Viral Hepatitis (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - February 4, 2020 Category: Infectious Diseases Tags: Gastroenterology Journal Article Source Type: news

Hepatitis B: New therapeutic approach may help to cure chronic hepatitis B infection
(Helmholtz Zentrum M ü nchen - German Research Center for Environmental Health) Researchers at Helmholtz Zentrum M ü nchen, Technical University of Munich (TUM) and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 3, 2020 Category: Infectious Diseases Source Type: news

What Do You Do For Breast Milk Jaundice?
Discussion Almost all infants in the first few days of life have some elevation of their bilirubin because of the various physiologic changes they undergo in the transition to extra-uterine life. This is a common problem managed by many different inpatient and outpatient healthcare providers. This hyperbilirubinemia is usually unconjugated and resolves in the first 1-2 weeks of life. However, when it does not resolve, health care providers have 3 general paths to follow when considering a cause: inadequate breast milk intake, an underlying organic cause or breast milk jaundice. Inadequate breastfeeding is not uncommon and...
Source: PediatricEducation.org - February 3, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Hepatitis C no longer an obstacle for transplant recipients
Sharon Price had come to grips with the notion that dialysis would soon be part of his life. Facing a long wait for a new kidney, he was 73 years old and his condition had grown progressively over two years. He was ready to begin the treatment, but first had a request for his doctors at Atrium Health’s Carolinas Medical Center. “I was going to do it [dialysis], no ifs and or buts,” Price says. “But I wanted to put it off for two months because it was summer, and I wanted to do spend time… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 1, 2020 Category: Pharmaceuticals Authors: Atrium Health Source Type: news

Hepatitis C no longer an obstacle for transplant recipients
Sharon Price had come to grips with the notion that dialysis would soon be part of his life. Facing a long wait for a new kidney, he was 73 years old and his condition had grown progressively over two years. He was ready to begin the treatment, but first had a request for his doctors at Atrium Health’s Carolinas Medical Center. “I was going to do it [dialysis], no ifs and or buts,” Price says. “But I wanted to put it off for two months because it was summer, and I wanted to do spend time… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 1, 2020 Category: Biotechnology Authors: Atrium Health Source Type: news

AbbVie Receives Positive CHMP Opinion for MAVIRET(R) (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks in Genotype 3, Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis
If approved by the European Commission (EC), MAVIRET will be the only pan-genotypic (GT1-6) 8-week treatment option for treatment-naïve, chronic hepatitis C (HCV) patients, without cirrhosis or with compensated cirrhosis Final European Commission ... Biopharmaceuticals, Regulatory AbbVie, MAVIRET, glecaprevir, pibrentasvir, hepatitis C (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 31, 2020 Category: Pharmaceuticals Source Type: news

HRSA: Notice Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment
Announcement of a meeting of the Centers for Disease Control and Prevention and Health Resources and Services Administration Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment to be held via webinar on March 5, 2020. The agenda includes a discussion of a pilot program on recency assay-based incidence estimation and the President'sEnding the HIV Epidemic: A Plan for America strategy. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - January 31, 2020 Category: Rural Health Source Type: news

£ 24m boost for Liverpool led revolutionary long-acting medicine research
(University of Liverpool) The University of Liverpool has been awarded more than £ 24.5 million ($32m) in funding from Unitaid to develop long-acting formulations for malaria and TB prevention, and a single-injection cure for hepatitis C. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 31, 2020 Category: Infectious Diseases Source Type: news

NPPA seeks clarification on Gilead's drug pricing plea
National Pharmaceutical Pricing Authority has sought clarifications from the company. Gilead had sought exemption from price control for its Tenofovir Alafenamide tablets (brand name Vemlidy) to capture a major chunk of Rs 140-crore market for chronic Hepatitis B in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 31, 2020 Category: Pharmaceuticals Source Type: news

Unique new antiviral treatment made using sugar
(University of Manchester) New antiviral materials made from sugar have been developed to destroy viruses on contact and may help in the fight against viral outbreaks. This new development from a collaborative team of international scientists shows promise for the treatment of herpes simplex (cold sore virus), respiratory syncytial virus, hepatitis C, HIV, and Zika virus to name a few. The team have demonstrated success treating a range of viruses in the lab - including respiratory infections to genital herpes. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 29, 2020 Category: Infectious Diseases Source Type: news

Liver Fibrosis, Function Improvement After HCV DAA Therapy Liver Fibrosis, Function Improvement After HCV DAA Therapy
This study demonstrates that successful DAA therapy for HCV provides an initial rapid resolution of liver inflammation followed by a steady improvement in liver fibrosis and metabolic liver function.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 27, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Roche submits supplemental Biologics License Application to the FDA for Tecentriq in combination with Avastin for the most common form of liver cancer
      ·Application is being reviewed under FDA ’s Real-Time Oncology Review pilot programmeBasel, 27 January 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the completion of a supplemental Biologics License Application (sBLA) submission to the US Food and Drug Administration (FDA) for Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab), for the treatment of people with unresectab le hepatocellular carcinoma (HCC) who have not received prior systemic therapy. The FDA is reviewing the application under the Real-Time Oncology Review pilot programme, wh...
Source: Roche Investor Update - January 27, 2020 Category: Pharmaceuticals Source Type: news

Treating Opioid Use Disorder, Infectious Diseases in an Integrated Way
The opioid epidemic in the U.S. is driving a simultaneous epidemic of infectious diseases— including HIV, hepatitis C virus (HCV) and bacterial infections, and sexually transmitted infections— but workforce shortages, stigma, and administrative burdens are preventing the integration of opioid use disorder (OUD) and infectious disease services, says a new report from the National Academies of Sciences, Engineering, and Medicine. It recommends a number of state and federal policy actions to address those barriers, including removing insurance requirements on prescribing medications for OUD (i.e., buprenorphine), ...
Source: News from the National Academies - January 23, 2020 Category: Science Source Type: news

Consensus recommendations for resistance testing in the management of chronic hepatitis C virus infection: Public Health England HCV Resistance Group
The authors describe the principles behind and approach to HCV resistance testing and consider evidence from in vitro studies, clinical trials and real world cohorts on the impact of HCV resistance on treatment outcomes for particular DAA regimens. Five scenarios are identified in the UK and similar settings, where, in the Group's opinion, resistance testing should be performed. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 23, 2020 Category: Consumer Health News Source Type: news

Antiviral treatments inspire researchers to develop a new kind of cancer drug
(Stanford University) An effort to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 22, 2020 Category: Cancer & Oncology Source Type: news

Lower Hepatoma Risk With Earlier ALT Normalization During HBV Treatment Lower Hepatoma Risk With Earlier ALT Normalization During HBV Treatment
Earlier normalization of alanine aminotransferase (ALT) levels during treatment of chronic hepatitis B is independently associated with a reduced risk of hepatocellular carcinoma (HCC), researchers from South Korea report.Reuters Health Information (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - January 21, 2020 Category: Transplant Surgery Tags: Hematology-Oncology News Source Type: news

Cost-effectiveness of HCV Testing in Community Pharmacies Cost-effectiveness of HCV Testing in Community Pharmacies
Is pharmacy-based targeted testing for HCV a cost-effective approach?Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 20, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Grant targets ‘perfect storm’ threatening lives
Armed with a $1.5 million grant, Yale School of Public Health researcher Gregg Gonsalves is taking on a surge in new cases of HIV and Hepatitis C. (Source: Yale Science and Health News)
Source: Yale Science and Health News - January 16, 2020 Category: Universities & Medical Training Source Type: news

Heart Transplants From Donors With Hepatitis C May Be Safe: Study
Title: Heart Transplants From Donors With Hepatitis C May Be Safe: StudyCategory: Health NewsCreated: 1/13/2020 12:00:00 AMLast Editorial Review: 1/14/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - January 14, 2020 Category: Cardiology Source Type: news

Heart Transplants From Donors With Hepatitis C May Be Safe: Study
MONDAY, Jan. 13, 2020 -- One-year survival rates are similar for transplant patients who receive a heart from a donor with hepatitis C or one without the infectious virus, a new study finds. The researchers suggest that using hearts from donors with... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 13, 2020 Category: General Medicine Source Type: news

Coblopasvir and Sofosbuvir in Patients With HCV Infection Coblopasvir and Sofosbuvir in Patients With HCV Infection
This study investigated the safety and efficacy of coblopasvir plus sofosbuvir in a broad range of HCV infections, including those with compensated cirrhosis.Journal of Viral Hepatitis (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 13, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

First robust cell culture model for the hepatitis E virus
(Ruhr-University Bochum) A mutation switches the turbo on during virus replication. This is a blessing for research. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - January 13, 2020 Category: Infectious Diseases Source Type: news

Namibia: Hepatitis E Infections Still Rife in the Country - Break 7000 Mark
[Namibia Economist] The Ministry of Health and Social Service recently revealed that the country has recorded a 65% increase in new infections of hepatitis E. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 9, 2020 Category: African Health Source Type: news

Heart Transplants From Hep C Virus-Positive Donors Seem Safe
WEDNESDAY, Jan. 8, 2020 -- Adult heart transplants from hepatitis C virus-positive (HCV+) donors appear safe, with no increased risk for adverse effects on one-year survival, according to a study published online Jan. 8 in the Journal of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 8, 2020 Category: Pharmaceuticals Source Type: news

State starts year with 32 Hepatitis A cases
After facing a major outbreak last year, Florida had 32 reported cases of hepatitis A during the first four days of 2020, state Department of Health numbers show. Duval County led the state in the number of newly reported cases from last Wednesday to Saturday, with five, followed by Polk County, which had four cases. Totals posted on the  Department of Health website showed that 3,396 cases of hepatitis A were reported to the state in 2019, up from 548 c ases in 2018. Hepatitis A can cause liver… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 8, 2020 Category: Pharmaceuticals Source Type: news

Heart transplants from donors with hepatitis C may be safe and could help decrease organ shortage
(American Heart Association) One-year survival was 90% for adults with severe heart failure who received a heart transplant from a donor with hepatitis C, which was nearly identical to those who received a heart from donors who did not have hepatitis C (91%). Rates of organ rejection, stroke and kidney dialysis were similar between the two groups. More research is needed to assess longer-term results, however, increased use of hearts from donors with hepatitis C could help overcome the national shortage of donor organs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 8, 2020 Category: International Medicine & Public Health Source Type: news